Measurement of antiretroviral drugs in the lungs of HIV-infected patients

Homer Twigg, Carol T. Schnizlein-Bick, Michael Weiden, Fred Valentine, Joseph Wheat, Richard B. Day, Helen Rominger, Lu Zheng, Ronald G. Collman, Robert W. Coombs, R. Pat Bucy, Naser L. Rezk, Ngela DM Kashuba

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Aims: Prior studies have shown that HAART is associated with decreased HIV viral load in the lungs. The correlation between antiretroviral exposure in bronchoalveolar lavage (BAL) fluid and virologic response was evaluated in patients starting HAART and enrolled in The AIDS Clinical Trial Group Protocol 723. Materials & methods: A total of 24 subjects underwent blood and BAL sampling prior to starting HAART, and after 4 and 24 weeks of HAART. Drug concentrations and HIV RNA were measured in paired plasma and BAL samples. Results: Antiretroviral drugs, including efavirenz, were detectable in BAL fluid of HIV-infected subjects beginning HAART. Efavirenz was also associated with a higher likelihood of clearing HIV RNA from the lungs. Conclusion: These results suggest the excellent pulmonary virologic response to antiretroviral therapy may, in part, be due to penetration of antiretroviral drugs into the alveolar compartment.

Original languageEnglish
Pages (from-to)247-251
Number of pages5
JournalHIV Therapy
Volume4
Issue number2
DOIs
StatePublished - Mar 2010

Fingerprint

Highly Active Antiretroviral Therapy
efavirenz
HIV
Lung
Pharmaceutical Preparations
Bronchoalveolar Lavage Fluid
Bronchoalveolar Lavage
RNA
Clinical Protocols
Viral Load
Acquired Immunodeficiency Syndrome
Clinical Trials

Keywords

  • Bronchoalveolar lavage
  • Drug concentration
  • Efavirenz
  • HAART
  • HIV RNA
  • Lung

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases
  • Pharmacology (medical)
  • Drug Discovery
  • Pharmacology
  • Dermatology

Cite this

Twigg, H., Schnizlein-Bick, C. T., Weiden, M., Valentine, F., Wheat, J., Day, R. B., ... Kashuba, N. DM. (2010). Measurement of antiretroviral drugs in the lungs of HIV-infected patients. HIV Therapy, 4(2), 247-251. https://doi.org/10.2217/hiv.10.5

Measurement of antiretroviral drugs in the lungs of HIV-infected patients. / Twigg, Homer; Schnizlein-Bick, Carol T.; Weiden, Michael; Valentine, Fred; Wheat, Joseph; Day, Richard B.; Rominger, Helen; Zheng, Lu; Collman, Ronald G.; Coombs, Robert W.; Bucy, R. Pat; Rezk, Naser L.; Kashuba, Ngela DM.

In: HIV Therapy, Vol. 4, No. 2, 03.2010, p. 247-251.

Research output: Contribution to journalArticle

Twigg, H, Schnizlein-Bick, CT, Weiden, M, Valentine, F, Wheat, J, Day, RB, Rominger, H, Zheng, L, Collman, RG, Coombs, RW, Bucy, RP, Rezk, NL & Kashuba, NDM 2010, 'Measurement of antiretroviral drugs in the lungs of HIV-infected patients', HIV Therapy, vol. 4, no. 2, pp. 247-251. https://doi.org/10.2217/hiv.10.5
Twigg H, Schnizlein-Bick CT, Weiden M, Valentine F, Wheat J, Day RB et al. Measurement of antiretroviral drugs in the lungs of HIV-infected patients. HIV Therapy. 2010 Mar;4(2):247-251. https://doi.org/10.2217/hiv.10.5
Twigg, Homer ; Schnizlein-Bick, Carol T. ; Weiden, Michael ; Valentine, Fred ; Wheat, Joseph ; Day, Richard B. ; Rominger, Helen ; Zheng, Lu ; Collman, Ronald G. ; Coombs, Robert W. ; Bucy, R. Pat ; Rezk, Naser L. ; Kashuba, Ngela DM. / Measurement of antiretroviral drugs in the lungs of HIV-infected patients. In: HIV Therapy. 2010 ; Vol. 4, No. 2. pp. 247-251.
@article{9ee2bb8856fe42a89292df94148edec2,
title = "Measurement of antiretroviral drugs in the lungs of HIV-infected patients",
abstract = "Aims: Prior studies have shown that HAART is associated with decreased HIV viral load in the lungs. The correlation between antiretroviral exposure in bronchoalveolar lavage (BAL) fluid and virologic response was evaluated in patients starting HAART and enrolled in The AIDS Clinical Trial Group Protocol 723. Materials & methods: A total of 24 subjects underwent blood and BAL sampling prior to starting HAART, and after 4 and 24 weeks of HAART. Drug concentrations and HIV RNA were measured in paired plasma and BAL samples. Results: Antiretroviral drugs, including efavirenz, were detectable in BAL fluid of HIV-infected subjects beginning HAART. Efavirenz was also associated with a higher likelihood of clearing HIV RNA from the lungs. Conclusion: These results suggest the excellent pulmonary virologic response to antiretroviral therapy may, in part, be due to penetration of antiretroviral drugs into the alveolar compartment.",
keywords = "Bronchoalveolar lavage, Drug concentration, Efavirenz, HAART, HIV RNA, Lung",
author = "Homer Twigg and Schnizlein-Bick, {Carol T.} and Michael Weiden and Fred Valentine and Joseph Wheat and Day, {Richard B.} and Helen Rominger and Lu Zheng and Collman, {Ronald G.} and Coombs, {Robert W.} and Bucy, {R. Pat} and Rezk, {Naser L.} and Kashuba, {Ngela DM}",
year = "2010",
month = "3",
doi = "10.2217/hiv.10.5",
language = "English",
volume = "4",
pages = "247--251",
journal = "HIV Therapy",
issn = "1758-4310",
publisher = "Future Medicine Ltd.",
number = "2",

}

TY - JOUR

T1 - Measurement of antiretroviral drugs in the lungs of HIV-infected patients

AU - Twigg, Homer

AU - Schnizlein-Bick, Carol T.

AU - Weiden, Michael

AU - Valentine, Fred

AU - Wheat, Joseph

AU - Day, Richard B.

AU - Rominger, Helen

AU - Zheng, Lu

AU - Collman, Ronald G.

AU - Coombs, Robert W.

AU - Bucy, R. Pat

AU - Rezk, Naser L.

AU - Kashuba, Ngela DM

PY - 2010/3

Y1 - 2010/3

N2 - Aims: Prior studies have shown that HAART is associated with decreased HIV viral load in the lungs. The correlation between antiretroviral exposure in bronchoalveolar lavage (BAL) fluid and virologic response was evaluated in patients starting HAART and enrolled in The AIDS Clinical Trial Group Protocol 723. Materials & methods: A total of 24 subjects underwent blood and BAL sampling prior to starting HAART, and after 4 and 24 weeks of HAART. Drug concentrations and HIV RNA were measured in paired plasma and BAL samples. Results: Antiretroviral drugs, including efavirenz, were detectable in BAL fluid of HIV-infected subjects beginning HAART. Efavirenz was also associated with a higher likelihood of clearing HIV RNA from the lungs. Conclusion: These results suggest the excellent pulmonary virologic response to antiretroviral therapy may, in part, be due to penetration of antiretroviral drugs into the alveolar compartment.

AB - Aims: Prior studies have shown that HAART is associated with decreased HIV viral load in the lungs. The correlation between antiretroviral exposure in bronchoalveolar lavage (BAL) fluid and virologic response was evaluated in patients starting HAART and enrolled in The AIDS Clinical Trial Group Protocol 723. Materials & methods: A total of 24 subjects underwent blood and BAL sampling prior to starting HAART, and after 4 and 24 weeks of HAART. Drug concentrations and HIV RNA were measured in paired plasma and BAL samples. Results: Antiretroviral drugs, including efavirenz, were detectable in BAL fluid of HIV-infected subjects beginning HAART. Efavirenz was also associated with a higher likelihood of clearing HIV RNA from the lungs. Conclusion: These results suggest the excellent pulmonary virologic response to antiretroviral therapy may, in part, be due to penetration of antiretroviral drugs into the alveolar compartment.

KW - Bronchoalveolar lavage

KW - Drug concentration

KW - Efavirenz

KW - HAART

KW - HIV RNA

KW - Lung

UR - http://www.scopus.com/inward/record.url?scp=77951696598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951696598&partnerID=8YFLogxK

U2 - 10.2217/hiv.10.5

DO - 10.2217/hiv.10.5

M3 - Article

AN - SCOPUS:77951696598

VL - 4

SP - 247

EP - 251

JO - HIV Therapy

JF - HIV Therapy

SN - 1758-4310

IS - 2

ER -